MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma

Yang Yuan1, Zhi-Yong Zeng, Xiao-Hong Liu

  • 1Institute of Cardiothoracic Surgery, Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai, PR China.

BMC Cancer
|February 9, 2011
PubMed
Abstract

Insights

MicroRNA-203 (miR-203) inhibits esophageal squamous cell carcinoma (ESCC) cell proliferation by downregulating ΔNp63. This suggests miR-203 may serve as a potential therapeutic agent for ESCC treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Esophageal squamous cell carcinoma (ESCC) is a significant global health concern.
  • The roles of microRNA-203 (miR-203) and ΔNp63 in ESCC progression are not fully understood.
  • Investigating the interplay between miR-203 and ΔNp63 is crucial for understanding ESCC pathogenesis.

Purpose of the Study:

  • To investigate the effect of miR-203 and ΔNp63 on cell proliferation in ESCC.
  • To elucidate the functional connection between miR-203 and ΔNp63 in ESCC.
  • To explore the potential of miR-203 as a therapeutic agent for ESCC.

Main Methods:

  • Utilized human ESCC cell lines (Eca109, TE-1).
  • Assessed cell proliferation following transfection with miR-203 mimic or ΔNp63 siRNA.
  • Examined miR-203 regulation of ΔNp63 using luciferase reporter assays, RT-PCR, and Western blot.
  • Investigated the impact of ΔNp63 re-expression on miR-203's anti-proliferative effects.

Main Results:

  • Both miR-203 and ΔNp63 siRNA significantly inhibited ESCC cell proliferation.
  • miR-203 was found to down-regulate endogenous ΔNp63 expression post-transcriptionally.
  • Re-expression of ΔNp63 attenuated the miR-203-induced inhibition of cell proliferation.

Conclusions:

  • miR-203 inhibits cell proliferation in human ESCC via a ΔNp63-mediated signaling pathway.
  • The findings suggest that miR-203 holds potential as a therapeutic agent for human ESCC.
  • Targeting the miR-203/ΔNp63 axis could be a promising strategy for ESCC treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...